Cargando…
The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice
BACKGROUND AND AIM: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of surgical infection, and its resistance to numerous conventional antibiotics makes treatment difficult. Although vancomycin is often an effective agent for the initial therapy of MRSA, clinical f...
Autores principales: | Hajiahmadi, Fahimeh, Alikhani, Mohammad Yousef, Shariatifar, Hanifeh, Arabestani, Mohammad Reza, Ahmadvand, Davoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683660/ https://www.ncbi.nlm.nih.gov/pubmed/31447553 http://dx.doi.org/10.2147/IJN.S214521 |
Ejemplares similares
-
The bactericidal effect of liposomal vancomycin as a topical combating system against Methicillin-resistant Staphylococcus aureus skin wound infection in mice
por: Hajiahmadi, Fahimeh, et al.
Publicado: (2019) -
Detection of Integrons and Staphylococcal Cassette Chromosome mec Types in Clinical Methicillin-resistant Coagulase Negative Staphylococci Strains
por: Hajiahmadi, Fahimeh, et al.
Publicado: (2017) -
In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus
por: Narasimhaswamy, Nagalakshmi, et al.
Publicado: (2017) -
A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform
por: Nour El-Din, Hanzada T., et al.
Publicado: (2020) -
Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia
por: Chen, Chen, et al.
Publicado: (2014)